Anne Greist is an Oncology physician affiliated with Indiana Hemophilia and Thrombosis Center. OpenAlex indexes 33 publications with 485 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8326 Naab Rd
Indianapolis, IN 462601920
Telephone
317-871-0000Provider last certified this registry record 8 Mar 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Pharmacyclics LLC, An AbbVie CompanyProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
58.8%Factor Xa inhibitor40.2%Eliquis62%Xarelto38%Part D≥29 patientsVitamin K antagonist6.4%Warfarin Sodium100%Part D≥16 patients+ 3 more classes in this area
Nervous system
27.6%Opioid Agonist24.3%Hydromorphone Hcl32%Morphine Sulfate Er26%Oxycodone Hcl17%Methadone Hcl15%Morphine Sulfate10%Part D<11 patientsGabapentinoids3.4%Gabapentin100%Part D<11 patientsCancer & immunology
13.5%Nonsteroidal Anti-inflammatory Drug7%Celecoxib100%Part D<11 patientsAntimetabolite4.4%Hydroxyurea100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1997–1999 per NIH RePORTER. The latest:
- LIPOSOMAL DOXORUBICIN WITH/WITHOUT BLEOMYCIN &VINCRISTINE FOR AIDS
Indiana Univ-Purdue Univ at Indianapolis
FY1999M01RR000750 - LIPOSOMAL DOXORUBICIN WITH/WITHOUT BLEOMYCIN &VINCRISTINE FOR AIDS
Indiana Univ-Purdue Univ at Indianapolis
FY1999M01RR000750 - LIPOSOMAL DOXORUBICIN WITH/WITHOUT BLEOMYCIN &VINCRISTINE FOR AIDS
Indiana Univ-Purdue Univ at Indianapolis
FY1998M01RR000750
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Building a Comprehensive Sickle Cell Disease Program in Western Kenya: A Decade of Experience and Growth
Annals of Global Health
2026 - Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders
European Journal Of Haematology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Amro Elshoury, MD
Indiana Hemophilia and Thrombosis Center
Charles Nakar, MD
Indiana Hemophilia and Thrombosis Center
Magdalena Lewandowska, MD
Indiana Hemophilia and Thrombosis Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”